|
American Academy of CME |
Share:
|
OverviewThe American Academy of CME, Inc. (Academy) is a not-for-profit educational foundation focused on providing high-quality, certified continuing education activities that improve the competence of healthcare professionals and change their behavior to positively impact patient care. The Academy, along with the associations and medical education companies with which it partners, have developed educational activities for physicians specialists and primary care), nurses, pharmacists, registered dietitians, transplant coordinators, and social workers. The Academy and its partners have extensive experience in the creation and execution of educational activities across multiple live and enduring formats for varied and diverse health care audiences. Our team includes both clinical specialists and professionals qualified in the practice of adult education, including development of gap analyses and instructional design, content development, meeting planning and execution, and outcomes measurement. |
Ace the Case: Multiple Myeloma Presentation in the Community Setting
Effective treatment of multiple myeloma (MM) requires significant clinical coordination, as MM treatment plans are highly individualized. Treatment is influenced by many factors, including patient demographics, biomarkers, level of disease progression, response to previous treatments, individual treatment goals, and the preferred treatment paradigms of individual practitioners.
This education...
|
|
Ace the Case: Newly Diagnosed AML: Can Molecular Markers Direct Treatment?
Knowledge of the key management issues for patients with AML is critical. Patients receiving both standard chemotherapy and newer agents need to be monitored for, and educated about, the risk of infection, bleeding and potential adverse events associated with treatment. Early identification and intervention are critical to reduce the potential for serious adverse events and complications.
|
|
Ace the Case: Older Adult with Therapy-Related AML
Knowledge of the key management issues for patients with AML is critical Patients receiving both standard chemotherapy and newer agents need to be monitored for, and educated about, the risk of infection, bleeding and potential adverse events associated with treatment. Early identification and intervention are critical to reduce the potential for serious adverse events and complications.
|
|
Ace the Case: Persistent Anemia in a Patient with Chronic Kidney Disease
Series of three online cases addressing key issues of anemia in CKD patients.
|
|
Ace the Case: R/R MM After 4 Lines of Therapy: What are the options?
Effective treatment of multiple myeloma (MM) requires significant clinical coordination, as MM treatment plans are highly individualized. Treatment is influenced by many factors, including patient demographics, biomarkers, level of disease progression, response to previous treatments, individual treatment goals, and the preferred treatment paradigms of individual practitioners.
This education...
|
|
Ace the Case: Supporting Older Adults with AML
Knowledge of the key management issues for patients with AML is critical. Patients receiving both standard chemotherapy and newer agents need to be monitored for, and educated about, the risk of infection, bleeding and potential adverse events associated with treatment. Early identification and intervention are critical to reduce the potential for serious adverse events and complications.
|
|
Ace the Case: Treating First Multiple Myeloma Relapse in the Community Setting
Effective treatment of multiple myeloma (MM) requires significant clinical coordination, as MM treatment plans are highly individualized. Treatment is influenced by many factors, including patient demographics, biomarkers, level of disease progression, response to previous treatments, individual treatment goals, and the preferred treatment paradigms of individual practitioners.
This education...
|
|
Addressing Disparities and Systemic Racism in HIV Prevention
This free interactive CME/CNE-Certified webinar is designed for members of the care team to help you identify disparities and systemic racism in HIV prevention and care, and to identify and implement strategies with your team to combat them.
|
|
Best of ACTHIV 2022: Cardio-metabolic Complications of ART
This module will look at the epidemiology of cardiovascular disease in HIV, identify predictors of cardiometabolic risk of ART, and best practices the team can apply to the prevention and management of cardiometabolic risk in PWH.
At the completion of this educational activity, participants will:
Review the epidemiology of cardiovascular disease in HIV
Identify predictors of cardiometabol...
|
|
Best of ACTHIV 2022: Case-Based Management of Hepatitis C in Persons with HIV
At the completion of this educational activity, participants will:
Discuss pre-treatment Assessment, recommended regimens and on-treatment monitoring for simplified HCV treatment
Discuss some real-world HCV treatment issues related to choice of direct-acting antiviral (DAA) therapy in HIV-HCV coinfected patients
Identify relevant drug interactions of DAAs with antiretroviral therapy
|
|
Best of ACTHIV 2022: Dermatology for People with HIV
Description
This module explores how to recognize and treat common HIV dermatologic diseases the care team may encounter in clinical practice.
At the completion of this educational activity, participants will:
Recognize and treat common HIV dermatologic diseases
Apply lessons from global HIV dermatology to your practice setting
|
|
Best of ACTHIV 2022: Opportunistic Infection Cases in People with HIV
This module will provide an overview of opportunistic infections for the HIV care team. Part of the conference "HIV: the Basics" session, the module will explore what members of the care team should know about opportunistic infections.
At the completion of this educational activity, participants will:
Describe common opportunistic infections seen among persons with HIV
Cite reas...
|
|
Best of ACTHIV 2022: Principles of Antiretroviral Therapy
This module will review the HIV life cycle and targets for current antiretroviral agents, considerations for choosing an ART regimen, and resistance testing methods. Part of the conference "HIV: the Basics" session, this module provides both a solid grounding for newer HIV clinicians and a review of foundational concepts for more experienced care team members.
At the completion of t...
|
|
Best of ACTHIV 2022: Update on the Diagnosis and Treatment of STIs
This module will focus on the latest screening guidelines for common STIs among people with HIV, recommended strategies for diagnosing common STIs, and how you can work with your team to apply the 2021 CDC guidelines to practice.
At the completion of this educational activity, participants will:
Review the latest screening guidelines for common STIs among people with HIV.
Utilize recommen...
|
|
Cardiovascular Disease in People with HIV
Heart disease is increased in people with HIV and is a clinical and public health priority. This free interactive CME/CNE-Certified webinar is designed for members of the care team to help you work together to identify those at risk in your care and apply best practices for the prevention and management of cardiovascular disease in PWH.
|
|
Case Studies in HIV Testing: Deciding Who to Test and How to Discuss Results
According to the CDC, 1.2 million people aged 13 and older were living with HIV (PLWH) in the US at the end of 2019. The CDC HIV Care Continuum offers a snapshot of this population from diagnosis, linkage to medical care, retention in care, and viral suppression. Of the 1.2 million PLWH, 87% were diagnosed, 66% had received medical care, 50% were retained in care, and 57% had achieved viral supp...
|
|
Case Studies in Identifying and Addressing Intimate Partner Violence among People with HIV
The prevalence of intimate partner violence (IPV) is high among people with HIV (PWH). PWH who report IPV are more likely to have poor HIV-related health outcomes (i.e., limited retention in care and poor adherence to antiretroviral therapy), sexually transmitted infections, mental health disorders, and poor overall physical health. HIV care visits are an opportunity to assess for and address IP...
|
|
Case Studies in Initial HIV Management: When, What, and How
Antiretroviral therapy should be initiated for all persons with HIV immediately after (or as soon as possible after) an HIV diagnosis. HIV treatment guidelines are frequently updated and discuss optimal strategies for initiating antiretroviral therapy. Despite this support, it can still be challenging for the care team to start antiretroviral medications in a timely manner and select an optimal ...
|
|
Case Studies in Mental Health Screening and Team Care for People Living with HIV
Behavioral health and mental health issues are overrepresented in people living with HIV. These issues can negatively impact such important issues as initiating treatment, engagement and retention in care, and medication adherence. The consequences of less-than-optimal treatment of HIV leads to increased risk of HIV transmission, increased rates of infection, disease progression, poor health o...
|
|
Case Studies in Syphilis and Mpox: A STEP-HIV Initiative
Members of the HIV care team are confronting two growing challenges"one old and one new.
Syphilis rates reached a historic low in 2000/2001 but have since increased annually and have reached a disturbing trend nationally affecting all communities. People living with HIV (PLWH) are particularly vulnerable to this infection and its complications.
Cases of human monkeypox virus (which is...
|
|
Combating the Stigma of Opioid Addiction
This webinar will address the stigma of addiction and how that effects people with substance use disorders. Experts will discuss the ways in which stigma serves as a barrier to effective prevention, treatment and recovery and highlight resources available to help overcome it and begin to break down this stigma in society.
|
|
DOACs and Older Adults with NVAF (Part 1 of 3)
Direct acting oral anti-coagulants (DOACs) are a newer class of medications with emerging clinical recommendations and evidence for safe use. Cardiologists and pharmacists have key roles to play as part of the care team to help ensure efficacy and safety of DOACs within the severely ill patient population.
|
|
DOACs and Patients with Renal Impairment (Part 2 of 3)
Direct acting oral anti-coagulants (DOACs) are a newer class of medications with emerging clinical recommendations and evidence for safe use. Cardiologists and pharmacists have key roles to play as part of the care team to help ensure efficacy and safety of DOACs within the severely ill patient population.
|
|
GOCCNJ Summit: Improving Quality Care for People with Serious Illness
Did you know that New Jersey patients near the end of life are treated with more aggressive medical care than patients in any other state in the U.S.?
This high-intensity, high-cost care is often unwanted and burdensome to both patients and their caregivers. Key reasons for this burdensome care are the lack of knowledge about palliative and end-of-life care services, and comfort discussing th...
|
|
Key Questions Answered in the Management of Follicular Lymphoma
Advances in the treatment of FL have led to the approval of two novel agents and updates to clinical practice guidelines. Nurses have unique and often long-standing relationships with their patients who have FL and are trusted sources of information and support. Oncology nurses who care for patients with FL should be aware of treatment guideline changes and their impact on clinical practice. Rec...
|
|
Managing Clinical Expectations in Infections Due to Gram-Positive Bacteria
Activity Description
The number of formally ID-trained pharmacists and physicians are limited across the country. This means that there is a growing role for general pharmacists and non-ID physicians to optimally manage their patients’ antibiotics in the hospital or outpatient setting as well as fulfill necessary expert roles in antibiotic stewardship programs. In order to do so, physicians a...
|
|
Metastatic Colorectal Cancer: Targeting Key Clinical Issues for Oncology Nurses
New targeted therapies for metastatic colorectal cancer have increased the need for awareness, education, and training for oncology nursing professionals to better prepare them to confidently manage and educate patients.
Upon completion of this activity, participants should be better able to:
Assess appropriate treatment options for a patient with mCRC who has failed first- and second-line...
|
|
OACs and Patients with Malignancies (Part 3 of 3)
Direct acting oral anti-coagulants (DOACs) are a newer class of medications with emerging clinical recommendations and evidence for safe use. Cardiologists and pharmacists have key roles to play as part of the care team to help ensure efficacy and safety of DOACs within the severely ill patient population.
|
|
The American Conference for the Treatment of HIV™ (ACTHIV™)
The American Conference for the Treatment of HIV™ (ACTHIV™) is the premier conference in the US dedicated exclusively to the frontline care team and its members who are caring for persons living with or at risk of acquiring HIV. The conference delivers information on new developments and research findings that can be rapidly translated and directly applied to the clinical setting.
|
|